Real-World Experience of Using Etelcalcetide for Secondary Hyperparathyroidism in Community-Based Hemodialysis Centers in Singapore.
10.7759/cureus.48186
Saved in:
Main Author: | Khan, Behram Ali |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
Cureus, Inc.
2023
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/245731 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
A Real-World Experience of Hyperkalemia Management Using Sodium Zirconium Cyclosilicate in Chronic Hemodialysis: A Multicenter Clinical Audit.
by: Khan, Behram Ali
Published: (2023) -
Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients
by: Wacharee Seeherunvong, et al.
Published: (2018) -
Severe hyperparathyroidism is associated with nutritional impairment in maintenance hemodialysis patients
by: Disthabanchong S.
Published: (2023) -
Tixagevimab and Cilgavimab Administration for Hemodialysis Patients at Community-Based Dialysis Centers in Singapore as Pre-Exposure Prophylaxis for SARS-CoV-2 Infection
by: Khan, Behram A, et al.
Published: (2023) -
Sucroferric oxyhydroxide use in patients on haemodialysis – real-world experience from an Asian cohort
by: Khan, Behram Ali, et al.
Published: (2023)